Skip to main content
. Author manuscript; available in PMC: 2015 Dec 2.
Published in final edited form as: Ann Nucl Med. 2015 Aug 19;29(10):877–882. doi: 10.1007/s12149-015-1017-z

Table 1. Study cohort characteristics.

Patient # Age (years) Sex TNM stage at initial diagnosis Nephrectomy histology Time from nephrectomy to metastasis (months) Heng criteria prognostic group [12]
1 65 Male pT2a cN0M0 ccRCC, grade II 73 Favorable risk
2 61 Male pT3aN1M1 ccRCC, grade IIIa 0 Poor risk
3 54 Male pT1b cN0M0 ccRCC, grade III 11 Intermediate risk
4 47 Male pT2a cN0M0 ccRCC, grade III 16 Intermediate risk
5 58 Male pT1bN0M1 ccRCC, grade II 0 Intermediate risk
a

Biopsy of site of metastatic disease consistent with sarcomatoid ccRCC